Half-year report · HY
3645.TEDINET S100XFCO
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.3bn | 2025-06-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥6.1bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Operating income | ¥94m | 2025-06-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥48m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥165m | 2025-06-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥135m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥67m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥164m | 2025-06-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥59m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥91m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥68m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥17m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥110m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | ¥1m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥4.6bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥4.1bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2024-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥248m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥81m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥56m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥11m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥260m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥193m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥219m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.92 | 2025-06-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.64 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.89 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.0% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-06-01 → 2025-11-30 | ¥90,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-06-01 → 2025-11-30 | ¥90,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-06-01 → 2025-11-30 | ¥90,000 |
| Cloud Integrationreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥221m |
| Cloud Integrationreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥221m |
| Cloud Integrationreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥48m |
| Mediaplatformreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥484m |
| Mediaplatformreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥484m |
| Mediaplatformreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥235m |
| Medical B To Breportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥79m |
| Medical B To Breportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥76m |
| Medical B To Breportable segment | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥3m |
| Medical B To Breportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥11m |
| Medical Institution Management Supportreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥2.5bn |
| Medical Institution Management Supportreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥2.5bn |
| Medical Institution Management Supportreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥54m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥3.3bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥3.3bn |
| —segment total | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥3m |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥347m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-06-01 → 2025-11-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-06-01 → 2025-11-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-06-01 → 2025-11-30 | ¥347m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Cloud Integrationreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥219m |
| Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥219m |
| Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥41m |
| Mediaplatformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥546m |
| Mediaplatformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥546m |
| Mediaplatformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥279m |
| Medical B To Breportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥87m |
| Medical B To Breportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥87m |
| Medical B To Breportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥11m |
| Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥83m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥19m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥19m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥104m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥287m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2024-11-30 | ¥288m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 535
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)Mooreみらい監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高砂 晋平 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)佐藤 豊毅 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 2912520000 | JPY |
| Net sales (5-year summary) | InterimDuration | 3330488000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 6077796000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 67303000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 165259000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 134989000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | -17039000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 90540000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -68147000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | -2820000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 137739000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -38875000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 1890587000 | JPY |
| Net assets (5-year summary) | InterimInstant | 2014779000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1768791000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 4354368000 | JPY |
| Total assets (5-year summary) | InterimInstant | 4560017000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 4080462000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | -1.89 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 9.92 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -7.64 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.4246 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.4273 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.4205 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | -55688000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 247586000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -80857000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -23421000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | 11300000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -259725000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -20711000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 192880000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 219178000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 1423207000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 1904686000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1403702000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10773000 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 886460 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.0958 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |